By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

LifeCycle Pharma 

100 Park Avenue
13th Floor
New York  New York  10017  U.S.A.
Phone: 646-200-8500 Fax: 212-867-9403


SEARCH JOBS








Company News
LifeCycle Pharma Passing of Extraordinary General Meeting - Change of Company Name to Veloxis Pharmaceuticals A/S and Election of New Board Member 7/7/2011 6:01:14 AM
LifeCycle Pharma Drug Works as Well as Rival at Lower Dose; Share Gains 6/21/2011 6:32:15 AM
LifeCycle Pharma to Present at the 13th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/11/2011 6:26:45 AM
LifeCycle Pharma Announces Positive Results of Phase 2 Clinical Trial for LCP-Tacro(TM) in De Novo Liver Transplant Patients 1/6/2011 7:43:42 AM
LifeCycle Pharma Announces Completion of Fully Subscribed Equity Offering 1/6/2011 7:34:24 AM
LifeCycle Pharma Announces Positive Results of Phase 2 Clinical Trial for LCP-Tacro in De Novo Liver Transplant Patients 1/6/2011 6:28:33 AM
LifeCycle Pharma Receives Special Protocol Assessment (SPA) From FDA for LCP-Tacro(TM) Pivotal Phase 3 Study in De Novo Kidney Transplant Patients 8/12/2010 9:39:57 AM
LifeCycle Pharma Submits the Phase 3 Protocol for LCP-Tacro(TM) (De No Kidney) to the FDA 12/23/2009 10:04:27 AM
LifeCycle Pharma Receives Notice of Allowance for U.S. Patent on Fenoglide(R) 12/17/2009 9:49:25 AM
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief Executive Officer 12/2/2009 6:33:33 AM
12345678910
//-->